Arcturus is advancing its vaccine and rare disease pipeline with significant developments. The initiation of a BARDA-funded Phase 1 study for bird flu, along with ongoing studies in cystic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback